As an oncogene, Rmp is amplified and overexpressed in many malignancies, such as ovarian cancer [21], hepatocellular carcinoma [9, 12], prostate cancer [22], cholangiocarcinoma [13], and colorectal cancer [23]. This evidence concerns the gene URI1 and prostate cancer.